Cabaletta Bio Stock Performance
| CABA Stock | USD 2.20 0.12 5.77% |
The firm shows a Beta (market volatility) of 1.27, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cabaletta Bio will likely underperform. At this point, Cabaletta Bio has a negative expected return of -0.13%. Please make sure to confirm Cabaletta Bio's total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if Cabaletta Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cabaletta Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return 5.77 | Year To Date Return (0.45) | Ten Year Return (78.00) | All Time Return (78.00) |
1 | Cabaletta Bio Reports Positive Rese-cel Data Across Myositis, SSc, and SLE Trials | 10/31/2025 |
2 | Cabaletta Bio Evaluating Valuation After Positive Clinical Data at ACR Convergence 2025 | 11/04/2025 |
3 | Will Cabaletta Bio Inc. stock outperform Nasdaq index - Swing Trade Free Risk Controlled Daily Trade Plans - newser.com | 11/06/2025 |
4 | Disposition of 22000 shares by Simon Mark of Cabaletta Bio at 10.01 subject to Rule 16b-3 | 11/11/2025 |
5 | Is Cabaletta Bio Inc. stock a contrarian buy - 2025 Trading Volume Trends Safe Capital Investment Plans - Fundao Cultural do Par | 11/14/2025 |
6 | How Cabaletta Bio Inc. stock performs in rising dollar environment - Weekly Volume Report Weekly High Conviction Ideas - newser.com | 11/18/2025 |
7 | Will Cabaletta Bio Inc. stock split again soon - Quarterly Investment Review AI Based Buy and Sell Signals - DonanmHaber | 12/19/2025 |
8 | Is Cabaletta Bio Inc. stock a top momentum play - Jobs Report Low Risk Investment Opportunities - ulpravda.ru | 01/08/2026 |
9 | Cabaletta Bio stock rating reiterated by Cantor Fitzgerald on IND clearance By Investing.com - Investing.com South Africa | 01/16/2026 |
| Begin Period Cash Flow | 193.2 M | |
| Total Cashflows From Investing Activities | 47.3 M |
Cabaletta | Build AI portfolio with Cabaletta Stock |
Cabaletta Bio Relative Risk vs. Return Landscape
If you would invest 282.00 in Cabaletta Bio on October 20, 2025 and sell it today you would lose (62.00) from holding Cabaletta Bio or give up 21.99% of portfolio value over 90 days. Cabaletta Bio is currently does not generate positive expected returns and assumes 7.771% risk (volatility on return distribution) over the 90 days horizon. In different words, 69% of stocks are less volatile than Cabaletta, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cabaletta Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cabaletta Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cabaletta Bio, and traders can use it to determine the average amount a Cabaletta Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0171
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CABA |
Based on monthly moving average Cabaletta Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cabaletta Bio by adding Cabaletta Bio to a well-diversified portfolio.
Cabaletta Bio Fundamentals Growth
Cabaletta Stock prices reflect investors' perceptions of the future prospects and financial health of Cabaletta Bio, and Cabaletta Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cabaletta Stock performance.
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 77.63 M | ||||
| Shares Outstanding | 96.27 M | ||||
| Price To Earning | (3.33) X | ||||
| Price To Book | 1.52 X | ||||
| EBITDA | (110.3 M) | ||||
| Net Income | (115.86 M) | ||||
| Cash And Equivalents | 96.81 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 15.6 M | ||||
| Debt To Equity | (3.76) % | ||||
| Current Ratio | 15.22 X | ||||
| Book Value Per Share | 1.45 X | ||||
| Cash Flow From Operations | (88.22 M) | ||||
| Earnings Per Share | (2.40) X | ||||
| Market Capitalization | 211.78 M | ||||
| Total Asset | 185.05 M | ||||
| Retained Earnings | (349.1 M) | ||||
| Working Capital | 139.59 M | ||||
| Current Asset | 30.42 M | ||||
| Current Liabilities | 843.74 K | ||||
About Cabaletta Bio Performance
By analyzing Cabaletta Bio's fundamental ratios, stakeholders can gain valuable insights into Cabaletta Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cabaletta Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cabaletta Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.72) | (0.76) | |
| Return On Capital Employed | (0.91) | (0.87) | |
| Return On Assets | (0.72) | (0.76) | |
| Return On Equity | (0.87) | (0.83) |
Things to note about Cabaletta Bio performance evaluation
Checking the ongoing alerts about Cabaletta Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cabaletta Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cabaletta Bio generated a negative expected return over the last 90 days | |
| Cabaletta Bio has high historical volatility and very poor performance | |
| Net Loss for the year was (115.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cabaletta Bio currently holds about 96.81 M in cash with (88.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cabaletta Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 74.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Cabaletta Bio stock rating reiterated by Cantor Fitzgerald on IND clearance By Investing.com - Investing.com South Africa |
- Analyzing Cabaletta Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cabaletta Bio's stock is overvalued or undervalued compared to its peers.
- Examining Cabaletta Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cabaletta Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cabaletta Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cabaletta Bio's stock. These opinions can provide insight into Cabaletta Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |